… brain diseases like brain tumour have remained formidable owing to poor prognosis and the
challenging drug delivery to the brain … in brain-specific delivery of chemotherapeutic agents. …

… Lipid nanoparticles loaded with doxorubicin have been investigated as a potential drug
carrier to the brain, although doxorubicin cannot cross the BBB. The pharmacokinetics and …

… spare normal tissue and destroy tumour cells, is changing the … of drugs to tumours of the
central nervous system, discuss current trends and directions in the development of novel drugs …

… level of drug and … drug delivery into the brain parenchyma in the context of fluid and solute
transport into, through and from the brain, with a focus on liposome and polymer drug carriers. …

… the blood–brain barrier and the blood–brain tumour barrier. This review will discuss the
challenges of drug delivery across the blood–brain barrier/blood–brain tumour barrier to cancer …

… The major biological challenge is to identify efficient targets on brain tumors, an issue which
basically applies to all of the approaches involving drug carrier systems discussed below. …

… interference drugs) across the BBB; and (v) particulate drug carrier … drug delivery to the
brain. Recently, microchips and biodegradable polymers have become important in brain tumour …

… Brain tumours are among the most feared of all forms of … primary brain tumour is a type of
astrocytoma (a tumour that forms … .recent advances in novel drug carrier systems. 2012; 10740. …

… Colloidal systems, such as liposomes and nanoparticles, have shown promising features
as drug carriers to target brain tumors after intravenous administration, and this technology is …

… In this review, we summarize the recently investigated nanodrug carrier platforms for brain
tumor … were used as a drug carrier with improved penetration ability for effective drug delivery. …